Omadacycline
2 FDA-DMF suppliersSmall Molecule
Overview
Omadacycline is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1689772).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Omadacycline expires 31 Oct 2037 and exclusivity 1 Oct 2028. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.